| Study of DARE-HRT1 Over 12 Weeks in Healthy PostMenopausal Women (NCT05367973) | Daré Bioscience, Inc. | 2022-04-11 |
| GRACE-trial: a Randomized Active-controlled Trial for vulvovaGinal atRophy in breAst Cancer Patients on Endocrine Therapy. (NCT05562518) | University Hospital, Ghent | 2022-03-21 |
| Non-hormonal Medical Device for Treatment of Vulvovaginal Atrophy (VVA) in Post-Menopausal Women (NCT04887701) | Madorra | 2021-07-09 |
| Effects of Visnadin, Ethyl Ximeninate, Coleus Barbatus and Millet in Emulgel on Sexual Function in Postmenopausal Women (NCT04579991) | Chulalongkorn University | 2021-05-27 |
| Local DHEA and Estradiol on Dyspareunia in Postmenopausal Women (NCT05586711) | Angelica Lindén Hirschberg | 2020-12-18 |
| Photobiomodulation Effect on Vulvovaginal Atrophy in Postmenopausal Women. (NCT04487392) | University of Nove de Julho | 2020-12-15 |
| Pilot Clinical Trial of IDRACARE® in Moderate to Severe Symptoms of Vulvovaginal Atrophy (NCT04766957) | Procare Health Iberia S.L. | 2020-10-26 |
| A Phase 1, Open-Label, Parallel Group Study to Evaluate the Pharmacokinetics and Safety of DARE-HRT1 in Healthy PostMenopausal Women (NCT05418426) | Daré Bioscience, Inc. | 2020-08-18 |
| Women's Satisfaction and Adherence to Vulvovaginal Atrophy Treatments (NCT04607707) | Shionogi | 2020-07-07 |
| Investigation of Efficacy and Tolerability of a Lactic Acid Containing Vaginal Suppository in Post-menopausal Women With VVA (NCT04222647) | Dr. August Wolff GmbH & Co. KG Arzneimittel | 2020-01-27 |
| Efficacy and Safety of Hyaluronic Acid Injection on Symptoms of Vulvovaginal Atrophy in Postmenopausal Women (NCT04219722) | Laboratoires Vivacy | 2020-01-21 |
| Evaluation of the Acceptability and Efficacy of 10 Micrograms of Estradiol Vaginal Tablets vs Promestriene Vaginal Cream (NCT04232813) | Instituto Palacios | 2020-01-09 |
| Performance and Safety of Class IIb MD Celegyn® in VVA (NCT03823560) | Nathura S.p.A | 2019-09-24 |
| RF and PEMF for Treatment of Vaginal Laxity and Mons Pubis and Labia for Improvement of Skin Laxity (NCT04210583) | Venus Concept | 2019-09-04 |
| Examining Effects of Intrarosa in Women With Genitourinary Syndrome of Menopause/Vulvovaginal Atrophy (NCT03782480) | Center for Vulvovaginal Disorders | 2019-03-02 |
| Performance and Safety of Hyalo Gyn Gel on the Treatment of Vaginal Atrophy in Postmenopausal Women (NCT04355403) | Fidia Farmaceutici s.p.a. | 2019-02-05 |
| Safety, Efficacy and Usage Compliance of the Silk'n Tightra Device (NCT03900143) | Home Skinovations Ltd. | 2019-01-28 |
| Multi-polar RF and PEMF for Treatment of Symptoms Associated With Vulvovaginal Atrophy (NCT03725410) | Venus Concept | 2018-09-25 |
| Sexual Penetration Pain in Postmenopausal Women: A Topical Botanical Drug Treatment (NCT03682601) | GTO Pharmaceutical, LLC | 2018-08-30 |
| Laser Therapy for Vulvovaginal Symptoms in Breast Cancer Patients (NCT03628092) | Royal North Shore Hospital | 2018-07-24 |
| Multi-polar RF and PEMF for Treatment of Vaginal Laxity and Mons Pubis and Labia for Improvement of Skin Laxity (NCT03536585) | Venus Concept | 2018-05-03 |
| Efficacy and Safety of HYDEAL-D Vaginal Pessaries Application on the Treatment of Vaginal Atrophy in Post-menopause Women (NCT03557398) | Fidia Farmaceutici s.p.a. | 2017-11-29 |
| Multi-polar RF and PEMF for Treatment of Vulvovaginal Atrophy (NCT04607798) | Venus Concept | 2017-10-03 |
| High Tone Pelvic Floor Dysfunction (NCT03083262) | St. Louis University | 2017-01-31 |
| Fractional Handpiece With CO2 Laser: Fractional Ablative Laser Treatment of Vulvovaginal Atrophy (NCT03271944) | SHERRY Thomas | 2016-12-29 |
| Visnadine, Prenylflavonoids and Bovine Colostrum to Treat Vulvovaginal Atrophy in Postmenopausal Women (NCT03281655) | University of Messina | 2016-12-01 |
| Vaginal Progesterone Versus Placebo for the Treatment of Vaginal Atrophy (NCT02460302) | Mount Sinai Hospital, Canada | 2016-12-01 |
| Investigation of Non-inferiority of Treatment of Vulvovaginal Dryness With WO2085 Moisturising Cream in Comparison to a Cream With 0.1% Estriol (NCT03044652) | Dr. August Wolff GmbH & Co. KG Arzneimittel | 2016-11-01 |
| Study to Evaluate Efficacy of Vagitocin in Postmenopausal Women With Vulvovaginal Atrophy Symptoms (NCT04629885) | PepTonic Medical AB | 2016-05-03 |
| Vulvoscopy Changes of the Vulva, Vestibule and Vagina With Daily Ospemifene in Women With Dyspareunia From VVA (NCT02784613) | Sue Goldstein | 2015-07-01 |
| Evaluation of Fractional CO2 Laser Treatment Efficacy and Comparison to Vaginal Estrogen Therapy in Postmenopausal Women With Vulvovaginal Atrophy (NCT02419729) | Faculdade de Medicina do ABC | 2015-03-01 |
| Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women (NCT02253173) | TherapeuticsMD | 2014-09-01 |
| Clinical Investigation to Assess the Safety and Efficacy of the Laser for the Treatment of Vulvovaginal Atrophy (NCT02085980) | El. En. SpA | 2014-03-01 |
| TXV13-01 Estradiol Vaginal Softgel Capsules in Treating Postmenopausal Women With Symptoms of Vulvar and Vaginal Atrophy (NCT02449902) | TherapeuticsMD | 2013-07-01 |
| Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women With Dyspareunia (NCT01845649) | Warner Chilcott | 2013-04-12 |
| Multicenter Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women (NCT01816139) | Warner Chilcott | 2013-01-31 |
| Evaluate Long-Term Safety and Efficacy WC3011 (Estradiol Vaginal Cream) (NCT01455597) | Warner Chilcott | 2011-10-20 |
| Postpartum Dyspareunia Resulting From Vaginal Atrophy (NCT01319968) | Meir Medical Center | 2011-03-01 |
| Investigation on the Efficacy of WO 2085 Moisturising Cream for Breast Cancer Patients Suffering From Vulvovaginal Dryness (NCT03593122) | Dr. August Wolff GmbH & Co. KG Arzneimittel | 2010-01-04 |
| Vaginal Microbiota Among Postmenopausal Women (NCT01084616) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2010-01-01 |